市場調查報告書
商品編碼
1500516
潤喉糖市場:按成分類型、類型、應用、分銷管道、應用分類 - 全球預測 2024-2030Throat Lozenges Market by Ingredient Type (Menthol Throat Lozenges, Non-Menthol Throat Lozenges), Type (Compressed Lozenges, Hard Candy Lozenges, Soft Lozenges), Usage, Distribution Channel, Application - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年潤喉糖市場規模為40.5億美元,預計2024年將達42.4億美元,2030年將達56.6億美元,複合年成長率為4.91%。
潤喉糖是一種小錠劑,可在口腔中緩慢溶解,通常用於暫時緩解輕度喉嚨痛和口腔發炎。這些含片含有薄荷醇、尤加利油、蜂蜜和各種草藥萃取物,具有緩解感冒、流感和過敏症狀、增加唾液分泌以緩解喉嚨乾燥等重要功效,甚至還具有抗菌特性,可以減少細菌的存在。 。由於多種因素,包括感冒和流感等呼吸道感染疾病的增加,以及空氣污染和過敏原增加導致的喉嚨不適,對潤喉糖的需求正在穩步增加。感冒藥的增加、流感等呼吸道感染疾病、空氣污染和過敏都會導致喉嚨痛。然而,市場面臨替代療法、與產品開發和商業化相關的嚴格法規、潛在副作用以及需求季節性波動等挑戰。儘管存在這些障礙,但未來的前景包括開拓創新產品以滿足不斷成長的消費者需求、擴展到新興市場、透過電子商務管道成長以及促進喉嚨健康的教育健康宣傳活動。
主要市場統計 | |
---|---|
基準年[2023] | 40.5億美元 |
預測年份 [2024] | 42.4億美元 |
預測年份 [2030] | 56.6億美元 |
複合年成長率(%) | 4.91% |
區域洞察
在美洲,潤喉糖市場正在穩定成長,由於呼吸道疾病、感冒和流感的盛行率日益增加,人們開始採用錠劑。此外,美國主要製藥公司的存在帶動了潤喉糖的技術創新。此外,人們對非處方治療的認知不斷增強,這也促進了該地區潤喉糖的銷售。尤其是在歐洲國家,在感冒發燒多發的冬季,潤喉糖的使用率很高。歐洲因其既定的藥物開發和商業化監管標準而吸引製造商。在中東和非洲,由於都市化的加速和醫療保健機會的改善,潤喉糖市場正在穩步成長。在亞太地區,潤喉糖市場正在經歷強勁成長。這是因為人口眾多,喉嚨感染疾病和呼吸道疾病的發生率較高,因此需要有效的治療。
FPNV定位矩陣
FPNV 定位矩陣對於評估喉嚨含片市場供應商的市場定位至關重要。此矩陣提供了對供應商的全面評估,並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對潤喉糖市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他關鍵指標。此外,該分析還提供了對該行業競爭性質的寶貴見解,包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對喉嚨含片市場當前地位的全面評估使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[189 Pages Report] The Throat Lozenges Market size was estimated at USD 4.05 billion in 2023 and expected to reach USD 4.24 billion in 2024, at a CAGR 4.91% to reach USD 5.66 billion by 2030.
Throat lozenges are small, medicated tablets designed to dissolve slowly in the mouth, which are commonly used to provide temporary relief for minor sore throat and mouth irritation. These lozenges, which often contain ingredients including menthol, eucalyptus oil, honey, and various herbal extracts, serve key functions, including symptom relief from colds, flu, allergies, increasing saliva production for dry throats, and even possessing antiseptic properties to reduce bacterial presence. The need for throat lozenges has been rising steadily due to multiple factors, which include increased respiratory infections such as colds and flu, exacerbated by growing air pollution and allergens, leading to throat discomfort. Their convenience and easy over-the-counter availability make them a popular choice for quick relief. However, the market faces challenges from alternative remedies, stringent regulations associated with product development and commercialization, possible side effects, and seasonal demand fluctuations. Despite these hurdles, future opportunities abound, including innovative product development to meet the increasing consumer need, expansion into emerging global markets, growth through eCommerce channels, and educational health campaigns promoting throat health.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 4.05 billion |
Estimated Year [2024] | USD 4.24 billion |
Forecast Year [2030] | USD 5.66 billion |
CAGR (%) | 4.91% |
Regional Insights
In the Americas, the throat lozenges market is growing steadily, with the adoption of this tablet owing to the increasing prevalence of respiratory issues, the common cold, and the flu. Moreover, the presence of major pharmaceutical companies in the United States leads to innovations in throat lozenges. Additionally, there is a rising awareness about over-the-counter treatments, which is helping to drive sales of throat lozenges in the region. European countries, in particular, have a high adoption of throat lozenges, especially during the winter months when colds and fevers are more common. Well-established regulatory standards for the development and commercialization of pharmaceutical products in Europe attract manufacturers. In the Middle East and Africa, the throat lozenges market is growing steadily, with increasing urbanization and better healthcare access. Asia-Pacific is experiencing robust growth in the throat lozenges market. This is driven by a large population and a need for effective treatment for high incidence of throat infections and respiratory ailments.
Market Insights
The market dynamics represent an ever-changing landscape of the Throat Lozenges Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Throat Lozenges Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Throat Lozenges Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Sirio Pharma Ventures into Consumer Health Market with Innovative Herbal Gummies
Sirio Pharma expanded its consumer health market footprint following its recent softgel launch by introducing a series of herbal gummies targeting trending health categories. The range includes three vegan, low-to-no sugar gummies intended to address key health concerns, including cough and cold, oral care, and urinary tract infections (UTI). The 'cough and cold' gummy, with its blend of citrus extract, eucalyptus, and acacia honey, aims to enhance the conventional throat lozenges category by providing improved texture and taste. [Published On: 2023-10-06]
Launch of Beekeeper's Naturals Kid's Propolis Throat Soothing Lollipops
Beekeeper's Naturals expanded its range of child-friendly supplements with the introduction of Kid's Propolis Throat Soothing Lollipops following its recent launch at Walmart. Formulated in collaboration with doctors and rigorously tested by third-party labs to ensure they are pesticide-free, these lollipops blend propolis, vitamin D, zinc, wildflower honey, and other clean ingredients to soothe sore throats and bolster immune health. [Published On: 2023-08-22]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Throat Lozenges Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Throat Lozenges Market, highlighting leading vendors and their innovative profiles. These include Bausch Health Companies Inc., Bliss GVS Pharma Ltd, Catalent, Inc., Cipla Limited, Dabur Ltd, Doetsch Grether AG, Ernest Jackson Ltd., Gepach International, GSK PLC, Island Abbey Foods Ltd., J. B. Chemicals & Pharmaceuticals Limited, Mondelez International, Inc., Pfizer Inc., Piramal Group, Prestige Consumer Healthcare Inc., Procter & Gamble Company, Reckitt Benckiser Group PLC, Ricola AG, Thornton & Ross Ltd, and Traditional Medicinals & WorldPantry.com LLC.
Market Segmentation & Coverage